In March it launched its first plastic-free toothbrush packaging, which included Sensodyne Pronamel and parodontax brushes in the US. Asia Pacific rollout of this commenced in Australia
The investment will establish drug product manufacturing capacity for clinical trial and commercial supply in China and offer customers combined drug substance and drug product manufacturing services
This year, the company plans to set up more than 200 labs and 3000 collection centres across the world and has ended FY 21 with a revenue of Rs 800 crores
The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market
The company expects a potential sales turnover of Rs.350-500 crores at 100 % capacity utilization
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
Formulation business grew by 15 per cent in the quarter
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
India business is growing as per projections; whereas US business will bounce back soon.
Subscribe To Our Newsletter & Stay Updated
